Midatech, Telormedix, Biopta Ltd., Molecular Profiles Ltd., University Hospital Zurich autoimmune news

Telormedix received €1.8 million ($2.3 million) from the EU's Eurostars Programme to coordinate a 23-month consortium aiming to develop new formulations of Telormedix's TMX-302 to treat psoriasis. Th...